Intensity of mystical experiences occasioned by 5-MeO-DMT and comparison with a prior psilocybin study

Joseph Barsuglia, Alan K. Davis, Robert Palmer, Rafael Lancelotta, Austin Marley Windham-Herman, Kristel Peterson, Martin Polanco, Robert Grant, Roland R Griffiths

Research output: Contribution to journalArticle

Abstract

5-MeO-DMT is a psychoactive substance found in high concentrations in the bufotoxin of the Colorado River Toad (Bufo alvarius). Emerging evidence suggests that vaporized 5-MeO-DMT may occasion mystical experiences of comparable intensity to those occasioned by more widely studied psychedelics such as psilocybin, but no empirical study has tested this hypothesis. Data was obtained from 20 individuals (Mage = 38.9, ± 10.7; male = 55%, Caucasian = 85%) who were administered 5-MeO-DMT as part of a psychospiritual retreat program in Mexico. All participants received 50 mg of inhaled vaporized toad bufotoxin which contains 5-MeO-DMT and completed the Mystical Experience Questionnaire (MEQ30) approximately 4-6 h after their session. Administration of 5-MeO-DMT occasioned strong mystical experiences (MEQ30 Overall Mintensity = 4.17, ± 0.64, range 0-5) and the majority (n = 15, 75%) had "a complete mystical experience" (≥60% on all MEQ30 subscales). Compared to a prior laboratory-based psilocybin study, there were no differences in the intensity of mystical effects between 5-MeO-DMT and a high dose (30 mg/70 kg) of psilocybin, but the intensity of mystical effects was significantly higher in the 5-MeO-DMT sample compared to moderate/high dose (20 mg/70 kg) of psilocybin (MEQ30 Total Score: p = 0.02, d = 0.81). Administration of vaporized 5-MeO-DMT reliably occasioned complete mystical experiences in 75% of individuals and was similar in intensity to high dose psilocybin administered in a laboratory setting. The short duration of action may be advantageous for clinical interventions and for studying mystical-type experiences.

Original languageEnglish (US)
Article number2459
JournalFrontiers in Psychology
Volume9
Issue numberDEC
DOIs
StatePublished - Dec 6 2018

Fingerprint

Psilocybin
Anura
Bufonidae
Hallucinogens
Mexico
Rivers

Keywords

  • 5-MeO-DMT
  • Bufo alvarius
  • Colorado river toad
  • DMT
  • Mystical experience
  • Psychedelic
  • Tryptamines

ASJC Scopus subject areas

  • Psychology(all)

Cite this

Intensity of mystical experiences occasioned by 5-MeO-DMT and comparison with a prior psilocybin study. / Barsuglia, Joseph; Davis, Alan K.; Palmer, Robert; Lancelotta, Rafael; Windham-Herman, Austin Marley; Peterson, Kristel; Polanco, Martin; Grant, Robert; Griffiths, Roland R.

In: Frontiers in Psychology, Vol. 9, No. DEC, 2459, 06.12.2018.

Research output: Contribution to journalArticle

Barsuglia, J, Davis, AK, Palmer, R, Lancelotta, R, Windham-Herman, AM, Peterson, K, Polanco, M, Grant, R & Griffiths, RR 2018, 'Intensity of mystical experiences occasioned by 5-MeO-DMT and comparison with a prior psilocybin study', Frontiers in Psychology, vol. 9, no. DEC, 2459. https://doi.org/10.3389/fpsyg.2018.02459
Barsuglia J, Davis AK, Palmer R, Lancelotta R, Windham-Herman AM, Peterson K et al. Intensity of mystical experiences occasioned by 5-MeO-DMT and comparison with a prior psilocybin study. Frontiers in Psychology. 2018 Dec 6;9(DEC). 2459. https://doi.org/10.3389/fpsyg.2018.02459
Barsuglia, Joseph ; Davis, Alan K. ; Palmer, Robert ; Lancelotta, Rafael ; Windham-Herman, Austin Marley ; Peterson, Kristel ; Polanco, Martin ; Grant, Robert ; Griffiths, Roland R. / Intensity of mystical experiences occasioned by 5-MeO-DMT and comparison with a prior psilocybin study. In: Frontiers in Psychology. 2018 ; Vol. 9, No. DEC.
@article{b07d0e8b8cad4a01af09f341b38eef10,
title = "Intensity of mystical experiences occasioned by 5-MeO-DMT and comparison with a prior psilocybin study",
abstract = "5-MeO-DMT is a psychoactive substance found in high concentrations in the bufotoxin of the Colorado River Toad (Bufo alvarius). Emerging evidence suggests that vaporized 5-MeO-DMT may occasion mystical experiences of comparable intensity to those occasioned by more widely studied psychedelics such as psilocybin, but no empirical study has tested this hypothesis. Data was obtained from 20 individuals (Mage = 38.9, ± 10.7; male = 55{\%}, Caucasian = 85{\%}) who were administered 5-MeO-DMT as part of a psychospiritual retreat program in Mexico. All participants received 50 mg of inhaled vaporized toad bufotoxin which contains 5-MeO-DMT and completed the Mystical Experience Questionnaire (MEQ30) approximately 4-6 h after their session. Administration of 5-MeO-DMT occasioned strong mystical experiences (MEQ30 Overall Mintensity = 4.17, ± 0.64, range 0-5) and the majority (n = 15, 75{\%}) had {"}a complete mystical experience{"} (≥60{\%} on all MEQ30 subscales). Compared to a prior laboratory-based psilocybin study, there were no differences in the intensity of mystical effects between 5-MeO-DMT and a high dose (30 mg/70 kg) of psilocybin, but the intensity of mystical effects was significantly higher in the 5-MeO-DMT sample compared to moderate/high dose (20 mg/70 kg) of psilocybin (MEQ30 Total Score: p = 0.02, d = 0.81). Administration of vaporized 5-MeO-DMT reliably occasioned complete mystical experiences in 75{\%} of individuals and was similar in intensity to high dose psilocybin administered in a laboratory setting. The short duration of action may be advantageous for clinical interventions and for studying mystical-type experiences.",
keywords = "5-MeO-DMT, Bufo alvarius, Colorado river toad, DMT, Mystical experience, Psychedelic, Tryptamines",
author = "Joseph Barsuglia and Davis, {Alan K.} and Robert Palmer and Rafael Lancelotta and Windham-Herman, {Austin Marley} and Kristel Peterson and Martin Polanco and Robert Grant and Griffiths, {Roland R}",
year = "2018",
month = "12",
day = "6",
doi = "10.3389/fpsyg.2018.02459",
language = "English (US)",
volume = "9",
journal = "Frontiers in Psychology",
issn = "1664-1078",
publisher = "Frontiers Research Foundation",
number = "DEC",

}

TY - JOUR

T1 - Intensity of mystical experiences occasioned by 5-MeO-DMT and comparison with a prior psilocybin study

AU - Barsuglia, Joseph

AU - Davis, Alan K.

AU - Palmer, Robert

AU - Lancelotta, Rafael

AU - Windham-Herman, Austin Marley

AU - Peterson, Kristel

AU - Polanco, Martin

AU - Grant, Robert

AU - Griffiths, Roland R

PY - 2018/12/6

Y1 - 2018/12/6

N2 - 5-MeO-DMT is a psychoactive substance found in high concentrations in the bufotoxin of the Colorado River Toad (Bufo alvarius). Emerging evidence suggests that vaporized 5-MeO-DMT may occasion mystical experiences of comparable intensity to those occasioned by more widely studied psychedelics such as psilocybin, but no empirical study has tested this hypothesis. Data was obtained from 20 individuals (Mage = 38.9, ± 10.7; male = 55%, Caucasian = 85%) who were administered 5-MeO-DMT as part of a psychospiritual retreat program in Mexico. All participants received 50 mg of inhaled vaporized toad bufotoxin which contains 5-MeO-DMT and completed the Mystical Experience Questionnaire (MEQ30) approximately 4-6 h after their session. Administration of 5-MeO-DMT occasioned strong mystical experiences (MEQ30 Overall Mintensity = 4.17, ± 0.64, range 0-5) and the majority (n = 15, 75%) had "a complete mystical experience" (≥60% on all MEQ30 subscales). Compared to a prior laboratory-based psilocybin study, there were no differences in the intensity of mystical effects between 5-MeO-DMT and a high dose (30 mg/70 kg) of psilocybin, but the intensity of mystical effects was significantly higher in the 5-MeO-DMT sample compared to moderate/high dose (20 mg/70 kg) of psilocybin (MEQ30 Total Score: p = 0.02, d = 0.81). Administration of vaporized 5-MeO-DMT reliably occasioned complete mystical experiences in 75% of individuals and was similar in intensity to high dose psilocybin administered in a laboratory setting. The short duration of action may be advantageous for clinical interventions and for studying mystical-type experiences.

AB - 5-MeO-DMT is a psychoactive substance found in high concentrations in the bufotoxin of the Colorado River Toad (Bufo alvarius). Emerging evidence suggests that vaporized 5-MeO-DMT may occasion mystical experiences of comparable intensity to those occasioned by more widely studied psychedelics such as psilocybin, but no empirical study has tested this hypothesis. Data was obtained from 20 individuals (Mage = 38.9, ± 10.7; male = 55%, Caucasian = 85%) who were administered 5-MeO-DMT as part of a psychospiritual retreat program in Mexico. All participants received 50 mg of inhaled vaporized toad bufotoxin which contains 5-MeO-DMT and completed the Mystical Experience Questionnaire (MEQ30) approximately 4-6 h after their session. Administration of 5-MeO-DMT occasioned strong mystical experiences (MEQ30 Overall Mintensity = 4.17, ± 0.64, range 0-5) and the majority (n = 15, 75%) had "a complete mystical experience" (≥60% on all MEQ30 subscales). Compared to a prior laboratory-based psilocybin study, there were no differences in the intensity of mystical effects between 5-MeO-DMT and a high dose (30 mg/70 kg) of psilocybin, but the intensity of mystical effects was significantly higher in the 5-MeO-DMT sample compared to moderate/high dose (20 mg/70 kg) of psilocybin (MEQ30 Total Score: p = 0.02, d = 0.81). Administration of vaporized 5-MeO-DMT reliably occasioned complete mystical experiences in 75% of individuals and was similar in intensity to high dose psilocybin administered in a laboratory setting. The short duration of action may be advantageous for clinical interventions and for studying mystical-type experiences.

KW - 5-MeO-DMT

KW - Bufo alvarius

KW - Colorado river toad

KW - DMT

KW - Mystical experience

KW - Psychedelic

KW - Tryptamines

UR - http://www.scopus.com/inward/record.url?scp=85058044144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058044144&partnerID=8YFLogxK

U2 - 10.3389/fpsyg.2018.02459

DO - 10.3389/fpsyg.2018.02459

M3 - Article

C2 - 30574112

AN - SCOPUS:85058044144

VL - 9

JO - Frontiers in Psychology

JF - Frontiers in Psychology

SN - 1664-1078

IS - DEC

M1 - 2459

ER -